MINNEAPOLIS, April 06, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-Driven Real-World Data (RWD), highlights its 2025 results, with robust revenue growth from the prior year, a strengthened balance sheet, and continued commercial momentum driven by Palantir Foundry enabled conversational search on Real-Time medical data from OneMedNet's rapidly growing network.

2025 Financial Highlights:

RWD Revenue Growth:

RWD revenue increased 329% year-over-year, rising from $292,000 in 2024 to $1,254,000 in 2025, reflecting strong market demand and increased commercial traction.

Fourth Quarter Revenue Acceleration:

Our work towards building and executing upon our strategy came together during the quarter ended December 31, 2025 with revenue surging to over $890,000.

Bookings Momentum:

Revenue growth is beginning to align with previously disclosed increases in bookings, reinforcing the Company's transition toward a scalable, subscription-based model.

Total Liabilities Reduced by 74%:

Total liabilities decreased from $19.7 million at December 31, 2024 to $5.1 million at December 31, 2025.

Driven by a combination of negotiated settlements and debt-to-equity conversions.

Equity Position Improved:

Shareholder deficit substantially reduced from $(16.0) million to $(3.0) million.

Building upon next commercial phase momentum:

Following its February 2026 announcement, OneMedNet entered a new phase of commercial execution centered on its AI-driven iRWD™ platform powered by Palantir Foundry, with the following commercial highlights:

2 Pilot Customers in contracting.

4 Additional customers expected in the second and third quarter of 2026, each representing a seven-figure subscription revenue ...